Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. CRWV
2. SMCI
3. LITE
4. ONON
5. CAVA
6. QNT
7. NCMI
8. FOCL
9. TME
10. ETOR

Go back to Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'

Harvard Bioscience (HBIO) Tops Q1 EPS by 2c

April 25, 2023 8:05 AM EDT

Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $30 million versus the consensus estimate of $28.95 million.


For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

... More